<DOC>
	<DOCNO>NCT02704013</DOCNO>
	<brief_summary>It single-center , prospective , interventional , single-arm study . Aim investigate variable significantly correlate prolonged anticholinergic treatment ( &gt; 6 month ) child overactive bladder ( OAB ) . Investigated variable include urinary neurotrophins inflammatory cytokine , sonographic biomarkers , symptom score scale , demographic , urodynamic finding . Secondary aim analyze sensitivity specificity urinary biomarkers diagnosis management OAB compare urodynamics treatment outcome .</brief_summary>
	<brief_title>Urinary Biomarkers Overactive Bladder Children</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Cholinergic Antagonists</mesh_term>
	<criteria>urgency without frequency , incontinence , enuresis , nocturia unremarkable clinical examination minimum 3 micturition per day inform oral write consent child parents/legal guardian acute urinary tract infection diseases central peripheral nerve system anomalies lumbosacral region bladder outlet obstruction operative procedure anomaly urinary genital tract hypercalcuria , diabetes mellitus , diabetes insipidus neurogenic bladder constipation fecal incontinence urolithiasis , depression , eat disorder cardiometabolic disease prior use anticholinergic treatment last year</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Neurotrophins</keyword>
	<keyword>Nerve Growth Factor</keyword>
	<keyword>Brain-Derived Neurotrophic Factor</keyword>
	<keyword>Urinary Biomarkers</keyword>
	<keyword>Urodynamics</keyword>
	<keyword>Anticholinergics</keyword>
	<keyword>Children</keyword>
</DOC>